0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Genetic analyses supporting colorectal, gastric, and prostate cancer syndromes

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Colorectal cancer (CRC), prostate cancer (PrC), and gastric cancer (GC) are common worldwide, and the incidence is to a certain extent dependent on genetics. We have recently shown that in families with more than one case of CRC, the risk of other malignancies is increased. We therefore suggested the presence of not yet described CRC syndromes. In this study, we have searched for genetic susceptibility loci for potential cancer syndromes involving CRC combined with PrC and/or GC. We have performed SNP (single‐nucleotide polymorphism)‐based linkage analyses in 45 families with CRC, PrC, and GC. In the regions with suggested linkage, we performed exome and association haplotype analyses. Five loci generated a high logarithm of odds (HLOD) score >2, suggestive of linkage, in chromosome bands 1q31‐32, 1q24‐25, 6q25‐26, 18p11‐q11, and Xp11. Exome analysis detected no potential pathogenic sequence variants. The haplotype association study showed that one of the top five haplotypes with the lowest P value in the chromosome band 6q25 interestingly was found in the family which contributed the most to the increased HLOD at that locus. This study supports a suggested hereditary cancer syndrome involving CRC and PrC and indicates a location at 6q25. The impact of this locus needs to be confirmed in additional studies.

          Related collections

          Most cited references18

          • Record: found
          • Abstract: not found
          • Article: not found

          A genetic model for colorectal tumorigenesis.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Serrated lesions of the colorectum: review and recommendations from an expert panel.

            Serrated lesions of the colorectum are the precursors of perhaps one-third of colorectal cancers (CRCs). Cancers arising in serrated lesions are usually in the proximal colon, and account for a disproportionate fraction of cancer identified after colonoscopy. We sought to provide guidance for the clinical management of serrated colorectal lesions based on current evidence and expert opinion regarding definitions, classification, and significance of serrated lesions. A consensus conference was held over 2 days reviewing the topic of serrated lesions from the perspectives of histology, molecular biology, epidemiology, clinical aspects, and serrated polyposis. Serrated lesions should be classified pathologically according to the World Health Organization criteria as hyperplastic polyp, sessile serrated adenoma/polyp (SSA/P) with or without cytological dysplasia, or traditional serrated adenoma (TSA). SSA/P and TSA are premalignant lesions, but SSA/P is the principal serrated precursor of CRCs. Serrated lesions have a distinct endoscopic appearance, and several lines of evidence suggest that on average they are more difficult to detect than conventional adenomatous polyps. Effective colonoscopy requires an endoscopist trained in the endoscopic appearance of serrated lesions. We recommend that all serrated lesions proximal to the sigmoid colon and all serrated lesions in the rectosigmoid > 5 mm in size, be completely removed. Recommendations are made for post-polypectomy surveillance of serrated lesions and for surveillance of serrated polyposis patients and their relatives.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer.

              Genetic and epigenetic alterations contribute to the pathogenesis of colorectal cancer (CRC). There is considerable molecular heterogeneity among colorectal tumors, which appears to arise as polyps progress to cancer. This heterogeneity results in different pathways to tumorigenesis. Although epigenetic and genetic alterations have been detected in conventional tubular adenomas, little is known about how these affect progression to CRC. We compared methylomes of normal colon mucosa, tubular adenomas, and colorectal cancers to determine how epigenetic alterations might contribute to cancer formation. We conducted genome-wide array-based studies and comprehensive data analyses of aberrantly methylated loci in 41 normal colon tissue, 42 colon adenomas, and 64 cancers using HumanMethylation450 arrays. We found genome-wide alterations in DNA methylation in the nontumor colon mucosa and cancers. Three classes of cancers and 2 classes of adenomas were identified based on their DNA methylation patterns. The adenomas separated into classes of high-frequency methylation and low-frequency methylation. Within the high-frequency methylation adenoma class a subset of adenomas had mutant KRAS. Additionally, the high-frequency methylation adenoma class had DNA methylation signatures similar to those of cancers with low or intermediate levels of methylation, and the low-frequency methylation adenoma class had methylation signatures similar to that of nontumor colon tissue. The CpG sites that were differentially methylated in these signatures are located in intragenic and intergenic regions. Genome-wide alterations in DNA methylation occur during early stages of progression of tubular adenomas to cancer. These findings reveal heterogeneity in the pathogenesis of colorectal cancer, even at the adenoma step of the process. Copyright © 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                annika.lindblom@ki.se
                Journal
                Genes Chromosomes Cancer
                Genes Chromosomes Cancer
                10.1002/(ISSN)1098-2264
                GCC
                Genes, Chromosomes & Cancer
                John Wiley & Sons, Inc. (Hoboken, USA )
                1045-2257
                1098-2264
                07 August 2019
                November 2019
                : 58
                : 11 ( doiID: 10.1002/gcc.v58.11 )
                : 775-782
                Affiliations
                [ 1 ] Department of Molecular Medicine and Surgery, Karolinska Institutet, and Department of Clinical Genetics Karolinska University Hospital Solna Stockholm Sweden
                [ 2 ] Department of Molecular Medicine and Surgery Karolinska Institutet Stockholm Sweden
                [ 3 ] Department of Medicine Solna Karolinska Institutet Stockholm Sweden
                Author notes
                [*] [* ] Correspondence

                Annika Lindblom, Department of Clinical Genetics L5:03, Karolinska University Hospital, Solna, SE‐17176 Stockholm, Sweden.

                Email: annika.lindblom@ 123456ki.se

                [†]

                Karin Wallander and Wen Liu contributed equally to this study.

                Author information
                https://orcid.org/0000-0001-9848-0468
                Article
                GCC22786
                10.1002/gcc.22786
                6771512
                31334572
                31b3eb7b-142d-4e0e-8199-344a67c64825
                © 2019 The Authors. Genes, Chromosomes & Cancer published by Wiley Periodicals, Inc.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 15 April 2019
                : 26 June 2019
                : 27 June 2019
                Page count
                Figures: 2, Tables: 3, Pages: 8, Words: 5951
                Funding
                Funded by: Cancerfonden
                Award ID: 160458
                Funded by: National Cancer Institute, National Institutes of Health (NCI/NIH), U.S. Department of Health and Human Services
                Award ID: U19 CA148107 R01 CA81488 P30 CA014089 R01 CA197
                Funded by: Stockholm County Council
                Award ID: ALF
                Funded by: The Stockholm Cancer Society
                Award ID: 161183
                Funded by: Vetenskapsrådet
                Award ID: K2015‐55X‐22674‐01‐4 K2008‐55X‐20157‐03‐3
                Funded by: Swedish Research Council
                Funded by: Science for Life Laboratory
                Funded by: Akademiska Sjukhuset
                Funded by: Uppsala Universitet
                Categories
                Research Article
                Research Articles
                Custom metadata
                2.0
                gcc22786
                November 2019
                Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.9 mode:remove_FC converted:01.10.2019

                Oncology & Radiotherapy
                colon,gastric cancer syndromes,prostate
                Oncology & Radiotherapy
                colon, gastric cancer syndromes, prostate

                Comments

                Comment on this article